<DOC>
	<DOC>NCT00636207</DOC>
	<brief_summary>A study to evaluate the safety, tolerability and pharmacokinetics of inhaled Montelukast (MK-0476) in participants with mild or moderate asthma.</brief_summary>
	<brief_title>A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Inhaled Montelukast (MK-0476) in Participants With Mild or Moderate Asthma (MK-0476-380 AM3)(COMPLETED)</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>Male or female between the ages of 18 and 65 Must have mild or moderate asthma (Part III only) Nonsmoker for at least 6 months History of stroke, chronic seizures or major neurological disorder You are nursing Drink more than 3 glasses of alcohol a day Have allergy to or not able to tolerate lactose Have a history of drug abuse in the last 5 years Drink more than 6 beverages containing caffeine a day Have had surgery, donated blood or participated in another investigational study in the last 4 weeks</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>March 2017</verification_date>
</DOC>